Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02024711 · ClinicalTrials.gov registry record · NA
EYEFILL® C. -US Viscoelastic Clinical Investigation
A NA study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT02024711 is a NA study that has completed, run by Bausch Health Americas. The registered enrollment target is 262 participants.
The verdict
NCT02024711, a NA study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this multicenter, prospective, randomized clinical study is to determine the safety and effectiveness of the EYEFILL® C.-US Viscoelastic in patients undergoing cataract extraction and intraocular lens (IOL) implantation surgery. EYEFILL® C.-US Viscoelastic is designed to create and maintain space, to protect the corneal endothelium and other intraocular tissues, and to manipulate tissues during surgery. EYEFILL® C.-US Viscoelastic may also be used to coat intraocular lenses and instruments during cataract extraction and intraocular lens insertion.
Interventions
- DEVICE EYEFILL® C.-US Viscoelastic
- DEVICE Healon® Viscoelastic (CONTROL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02024711
The ClinicalTrials.gov registry entry for NCT02024711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EYEFILL® C.-US Viscoelastic is the first listed.
NCT02024711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02024711 about?
NCT02024711 is a clinical study titled "EYEFILL® C. -US Viscoelastic Clinical Investigation". The purpose of this multicenter, prospective, randomized clinical study is to determine the safety and effectiveness of the EYEFILL® C.-US Viscoelastic in patients undergoing cataract extraction and intraocular lens (IOL) implantation surgery. EYEFILL® C.-US Viscoelastic is designed to create and m...
What is the current status of trial NCT02024711?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2013-12. Estimated completion is 2014-12-17.
What interventions are being tested in trial NCT02024711?
The interventions under investigation include: EYEFILL® C.-US Viscoelastic (DEVICE), Healon® Viscoelastic (CONTROL) (DEVICE).
Who is sponsoring clinical trial NCT02024711?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.